VANCOUVER, British Columbia – Lighthouse Genomics Inc. (“Lighthouse” or the “Company”), announces filing a US patent application and Canadian trademark applications in the months of July and August. The new Intellectual House (IP) holdings expand the company’s protection to operate with crucial branding and strategies in the rapid-increasing genomic sciences and bioinformatics industries.
The US patent application contains Lighthouse’s signature Genome Iris
diagram. The Genome Iris will be utilized by the Cannabis Authenticity and Purity Normal (CAPS) and the Purity-IQ (PIQ) Worldwide Cannabis Registry. The Normal and Registry problem Certificates of Evaluation drawing from a mixture of genomic and Nuclear Magnetic Resonance (NMR) analyses.
CAPS and the PIQ Worldwide Cannabis Registry give the Lighthouse Genome Iris
inside a suite of certification components constituting the cannabis industry’s most scientifically rigorous certification program. CAPS characterizes genetic assets and item specifications for the objective of IP protection and customer security.
“Cannabis buyers deserve assurance of a constant item – proof that flower, edibles and oils conform to a identified genomic and biochemical profile, verified by testing at points in the provide chain,” stated Timothy Harvey, CEO of Lighthouse Genomics.
“The Lighthouse Genome Iris
is developed as a fast visual reference of the special identity of a cannabis genome, or genovar – a special genomic selection inside a specific strain. This is essential, since what we generally contact ‘strains’ have a tendency to be poorly-defined and loaded with variability, causing item instability and confusion in the cannabis marketplace,” Harvey continued.
“The Genome Iris
can function as a barcode. Requirements primarily based on biometric barcodes conveying genomic and NMR information are the crucial to moving cannabis sales into much more formal retail settings such as pharmacies, exactly where item integrity is necessary. The advent of CAPS signals that the Cannabis market is getting into an era of confirmed item authenticity. This supports organization integrity, brand trust and customer satisfaction and security. Eventually this indicates development for the cannabis economy.”
The Cannabis Authenticity and Purity Normal and the PIQ Worldwide Cannabis Registry are brought to marketplace by means of strategic partnerships involving Purity-IQ, Lighthouse Genomics, NHP Study Alliance of the University of Guelph, Higher North Inc., Germany’s Bruker Corporation and an international network of cannabis laboratories. The group has carried out a Proof of Idea involving international producers, retailers and requirements organizations, and has created SOPs guided by input from market stakeholders.
Dr. Steven Newmaster, a Genomics Professor for 20 years at the University of Guelph states that “Lighthouse’s Genome Iris
is underpinned by a pan-genomic strategy that captures genomic variation that is much more extensive than other tools in the marketplace. This makes it possible for customers to interpret the Iris diagram inside the context of considerable breadth of genomic diversity captured with highly effective, however sophisticated bioinformatics.”
Lighthouse’s provisional patent application lists Dr. Anders Goncalves da Silva, the Company’s Chief Bioinformatics Officer, as inventor. Dr. Goncalves da Silva has a history of utilizing genomic information to influence government policy. He styles bioinformatics application and systems with an emphasis on surpassing all current accreditation and auditing requirements connected with genomic information.
Information visualizations covered by the provisional patent will also be utilized in a variety of Lighthouse items like Genovar
Reports, Cannabis Population Maps and marker-assisted breeding applications.
About Lighthouse Genomics
Lighthouse Genomics Inc. is a international leader in genetic information analytics for Cannabis sativa. Primarily based in British Columbia, Lighthouse transforms DNA into lucrative insights for breeders, producers, and brands. www.lighthousegenomics.com